Study Validating MoA of Intranasal Foralumab in Alzheimer’s Disease Published in the Prestigious Journal PNAS, Following FDA IND Clearance
September 06, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
The authors conclude that “nasal anti-CD3 has the potential to be a non-toxic novel immunotherapeutic approach for the treatment of Alzheimer’s disease (AD)”FDA has cleared the IND for intranasal...
Tiziana Life Sciences Announces Live Bloomberg TV Interview of Renowned Scientist Dr. Howard L. Weiner to Discuss FDA IND Clearance for Intranasal Foralumab in Alzheimer's Disease
August 17, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
BIOXCEL THERAPEUTICS, INC. INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies BioXcel Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
July 18, 2023 16:07 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of persons and entities that purchased or acquired securities...
Global Immunoassay for Neurological Biomarkers Market to 2030: Increasing Prevalence of Neurological Diseases Fuels the Sector
June 05, 2023 05:08 ET
|
Research and Markets
Dublin, June 05, 2023 (GLOBE NEWSWIRE) -- The "Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product, By Disease (Alzheimer's Disease, Parkinson's...
Tiziana Life Sciences to File Alzheimer’s IND for Intranasal Foralumab in Q2 2023
April 20, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
Application for $3M of non-dilutive funding for Phase 2a Alzheimer’s trial will be submitted in Q2 2023Tiziana guided by FDA Type “B” meeting comments on its scheduled Q2 2023 intranasal foralumab...
New Study: Lowering Dementia Risk Takes Less BrainHQ Training than Expected
April 11, 2023 08:00 ET
|
Posit Science
SAN FRANCISCO, April 11, 2023 (GLOBE NEWSWIRE) -- Researchers report a relatively small amount of brain training is required to reduce dementia risk in the Body, Brain, Life for Cognitive...
DAVOS ALZHEIMERS COLLABORATIVE FEATURED ON THE TODAY SHOW DURING WORLD ALZHEIMER’S AND HISPANIC HERITAGE MONTH
September 27, 2022 13:11 ET
|
Davos Alzheimer's Collaborative
Washington, DC, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The Davos Alzheimer’s Collaborative (DAC), the organization leading an unprecedented global response to Alzheimer’s disease,was featured on the NBC...
Alzheimer's Patient Advocates Launch Free Courses Promoting Brain Health
May 26, 2022 14:37 ET
|
UsAgainstAlzheimer's
Washington, D.C., May 26, 2022 (GLOBE NEWSWIRE) -- Today UsAgainstAlzheimer’s announced the launch of The Brain Health Academy (BHA), a new series of free online courses designed in partnership with...
DAVOS ALZHEIMER’S COLLABORATIVE ANNOUNCES PARTNERSHIP WITH AGA KHAN UNIVERSITY TO LAUNCH FIRST ALZHEIMER’S RESEARCH INITIATIVE IN EAST AFRICA
May 23, 2022 09:53 ET
|
Davos Alzheimer's Collaborative
GENEVA, SWITZERLAND, May 23, 2022 (GLOBE NEWSWIRE) -- Research Will Produce Digital Cognitive Assessments and Collect Blood Samples for Gene Sequencing Models Clinical Trial Will Conduct...
DAVOS ALZHEIMER’S COLLABORATIVE ANNOUNCES EARLY DETECTION INNOVATION GRANTS
May 23, 2022 09:14 ET
|
Davos Alzheimer's Collaborative
GENEVA, SWITZERLAND, May 23, 2022 (GLOBE NEWSWIRE) -- The Davos Alzheimer’s Collaborative (DAC), the organization leading an unprecedented global response to Alzheimer’s disease, today announced the...